Term
|
Definition
1) Reviewer Affaris Committee 2) Regulatory Affairs Certification 3) Recombinant DNA Advisory Committee |
|
|
Term
|
Definition
Refuse to File: letter sent by FDA when incomplete NDA or ANDA is filed. FDA will not review the application until complete. |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Substantially Equivalent: comparison of a new devcie to a legally marketed predicate device. SE establishes S&E. |
|
|
Term
|
Definition
Securities and Exchange Commission |
|
|
Term
|
Definition
|
|
Term
|
Definition
Significant Medical Event |
|
|
Term
|
Definition
Site Management Organization: a person that assumes, as an independnet contractor with the clinical investigator, one or more of the regulatory obligations of a clinical investigator |
|
|
Term
|
Definition
Standard Operating Procedure |
|
|
Term
|
Definition
|
|
Term
|
Definition
1) Single Rising Dose 2) Significant Risk Device |
|
|
Term
|
Definition
1) Single Use Device 2) Sudden Unexpected Death |
|
|
Term
|
Definition
Scale up and Post Approval Changes |
|
|
Term
|
Definition
|
|
Term
|
Definition
Unexpected Adverse Event: An AE whose nature or severity is not described in the investigator's brochure or in the Package Insert |
|
|
Term
|
Definition
United States Adopted Name: a nonproprietary designation for any compound used as a drug, established by negotiation between the manufacturer and the USAN council |
|
|
Term
|
Definition
|
|
Term
|
Definition
United States Department of Agriculture |
|
|
Term
|
Definition
United States Pharmacopoeia |
|
|
Term
|
Definition
Vaccine Adverse Event Reporting System: provides a database management system for the collection and analysis of data from adverse events following vaccination |
|
|
Term
|
Definition
Voluntary Action Inidicated: indicated on FDA form 483 following inspection. |
|
|
Term
|
Definition
World Health Organization |
|
|
Term
|
Definition
Warning Letter: M ost serious post-audit letter, requires action within 15 days |
|
|